RU2009126741A - Ингибиторы ренина, предназначенные для профилактики и лечения гипертензии у пациентов, страдающих от ожирения - Google Patents
Ингибиторы ренина, предназначенные для профилактики и лечения гипертензии у пациентов, страдающих от ожирения Download PDFInfo
- Publication number
- RU2009126741A RU2009126741A RU2009126741/15A RU2009126741A RU2009126741A RU 2009126741 A RU2009126741 A RU 2009126741A RU 2009126741/15 A RU2009126741/15 A RU 2009126741/15A RU 2009126741 A RU2009126741 A RU 2009126741A RU 2009126741 A RU2009126741 A RU 2009126741A
- Authority
- RU
- Russia
- Prior art keywords
- obesity
- pharmaceutically acceptable
- acceptable salt
- renin inhibitor
- bmi
- Prior art date
Links
- 239000002461 renin inhibitor Substances 0.000 title claims abstract 16
- 229940086526 renin-inhibitors Drugs 0.000 title claims abstract 16
- 208000008589 Obesity Diseases 0.000 title claims abstract 15
- 235000020824 obesity Nutrition 0.000 title claims abstract 15
- 206010020772 Hypertension Diseases 0.000 title claims abstract 9
- 238000011282 treatment Methods 0.000 title claims abstract 8
- 230000002265 prevention Effects 0.000 title claims abstract 4
- 238000000034 method Methods 0.000 claims abstract 24
- 150000003839 salts Chemical class 0.000 claims abstract 14
- 239000002934 diuretic Substances 0.000 claims abstract 9
- 230000001882 diuretic effect Effects 0.000 claims abstract 9
- 150000001875 compounds Chemical class 0.000 claims abstract 7
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 claims abstract 5
- 229960002003 hydrochlorothiazide Drugs 0.000 claims abstract 5
- 239000003814 drug Substances 0.000 claims abstract 4
- 238000004519 manufacturing process Methods 0.000 claims abstract 4
- 238000011321 prophylaxis Methods 0.000 claims abstract 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87018006P | 2006-12-15 | 2006-12-15 | |
| US60/870,180 | 2006-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009126741A true RU2009126741A (ru) | 2011-01-20 |
Family
ID=39186152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009126741/15A RU2009126741A (ru) | 2006-12-15 | 2007-12-13 | Ингибиторы ренина, предназначенные для профилактики и лечения гипертензии у пациентов, страдающих от ожирения |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100029775A1 (https=) |
| EP (1) | EP2094259A1 (https=) |
| JP (1) | JP2010513300A (https=) |
| KR (1) | KR20090090384A (https=) |
| CN (1) | CN101583355A (https=) |
| AU (1) | AU2007333095B2 (https=) |
| BR (1) | BRPI0721167A2 (https=) |
| CA (1) | CA2672579A1 (https=) |
| CL (1) | CL2007003628A1 (https=) |
| IL (1) | IL198876A0 (https=) |
| MA (1) | MA31003B1 (https=) |
| MX (1) | MX2009006340A (https=) |
| NO (1) | NO20092597L (https=) |
| RU (1) | RU2009126741A (https=) |
| TN (1) | TN2009000240A1 (https=) |
| TW (1) | TW200831071A (https=) |
| WO (1) | WO2008074001A1 (https=) |
| ZA (1) | ZA200903442B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2143425A1 (de) * | 2008-07-11 | 2010-01-13 | Ratiopharm GmbH | Direktverpresste Aliskiren-Tabletten |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| AR047880A1 (es) * | 2004-02-17 | 2006-03-01 | Novartis Ag | COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS |
| NZ549535A (en) * | 2004-03-17 | 2010-11-26 | Novartis Ag | Use of aliskiren for treating renal and other disorders |
| WO2007047351A2 (en) * | 2005-10-13 | 2007-04-26 | Orexigen Therapeutics, Inc. | Methods for treating hypertension in overweight and obese individuals |
| US20070293552A1 (en) * | 2006-06-15 | 2007-12-20 | Gorczynski Richard J | Antihypertensive therapy method |
-
2007
- 2007-12-13 KR KR1020097014655A patent/KR20090090384A/ko not_active Withdrawn
- 2007-12-13 AU AU2007333095A patent/AU2007333095B2/en not_active Ceased
- 2007-12-13 WO PCT/US2007/087322 patent/WO2008074001A1/en not_active Ceased
- 2007-12-13 MX MX2009006340A patent/MX2009006340A/es not_active Application Discontinuation
- 2007-12-13 BR BRPI0721167-8A patent/BRPI0721167A2/pt not_active IP Right Cessation
- 2007-12-13 JP JP2009541572A patent/JP2010513300A/ja not_active Withdrawn
- 2007-12-13 US US12/519,189 patent/US20100029775A1/en not_active Abandoned
- 2007-12-13 EP EP07865611A patent/EP2094259A1/en not_active Withdrawn
- 2007-12-13 RU RU2009126741/15A patent/RU2009126741A/ru not_active Application Discontinuation
- 2007-12-13 CA CA002672579A patent/CA2672579A1/en not_active Abandoned
- 2007-12-13 CN CNA2007800499179A patent/CN101583355A/zh active Pending
- 2007-12-14 CL CL200703628A patent/CL2007003628A1/es unknown
- 2007-12-14 TW TW096148110A patent/TW200831071A/zh unknown
-
2009
- 2009-05-19 ZA ZA200903442A patent/ZA200903442B/xx unknown
- 2009-05-21 IL IL198876A patent/IL198876A0/en unknown
- 2009-06-12 TN TNP2009000240A patent/TN2009000240A1/fr unknown
- 2009-06-17 MA MA32007A patent/MA31003B1/fr unknown
- 2009-07-08 NO NO20092597A patent/NO20092597L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009006340A (es) | 2009-06-23 |
| AU2007333095B2 (en) | 2011-03-24 |
| NO20092597L (no) | 2009-07-13 |
| WO2008074001A1 (en) | 2008-06-19 |
| CL2007003628A1 (es) | 2008-07-18 |
| TN2009000240A1 (en) | 2010-10-18 |
| BRPI0721167A2 (pt) | 2014-03-18 |
| KR20090090384A (ko) | 2009-08-25 |
| IL198876A0 (en) | 2010-02-17 |
| CN101583355A (zh) | 2009-11-18 |
| EP2094259A1 (en) | 2009-09-02 |
| US20100029775A1 (en) | 2010-02-04 |
| JP2010513300A (ja) | 2010-04-30 |
| CA2672579A1 (en) | 2008-06-19 |
| MA31003B1 (fr) | 2009-12-01 |
| TW200831071A (en) | 2008-08-01 |
| AU2007333095A1 (en) | 2008-06-19 |
| ZA200903442B (en) | 2010-05-26 |
| WO2008074001A8 (en) | 2009-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY148688A (en) | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors | |
| EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
| ATE384058T1 (de) | Thiazolderivate | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| BRPI0519124A2 (pt) | composto, mÉtodo para tratar, prevenir ou melhorar obesidade e doenÇas relacionadas e/ou sintomas das mesmas, composiÇço farmacÊutica, uso de composto, e, combinaÇço | |
| MY154591A (en) | Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor | |
| SE0301232D0 (sv) | Novel use | |
| EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
| SE0200667D0 (sv) | Novel use of cytokine inhibitors | |
| MA32240B1 (fr) | Inhibiteurs de désacétylases b à base d'hydroxamate | |
| MX2024005107A (es) | Nuevo uso de compuesto de quinazolinona para el tratamiento de cancer. | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| CL2004001050A1 (es) | Compuesto derivado de 3'-[4-oxo-3-{[(ciclopropil o 2,2,2-trifluoroetil)amino]carbonil}-1,8-naftiridin-1(4h)-il]-3-sustituido-1-1'-bifenil-4-il; composicion farmaceutica; y uso en el tratamiento o prevencion de asma, bronquitis cronica, enfermedad pul | |
| RU2011108486A (ru) | ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ПЕПТИДА Wnt5-a ДЛЯ ЛЕЧЕНИЯ МЕЛАНОМЫ И РАКА ЖЕЛУДКА | |
| PE20010541A1 (es) | Uso de una composicion de benzimidazol para tratar el cancer | |
| ATE357453T1 (de) | Comt-inhibitoren | |
| IL195016A0 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
| UA96304C2 (en) | 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | |
| MX2022012881A (es) | Inhibidores de replicacion del virus de inmunodeficiencia humana. | |
| MY133527A (en) | Isoquinoline derivatives | |
| EP1948161A4 (en) | METHOD FOR PREVENTING AND TREATING PPAR-MEDIATED CONDITIONS WITH MACELIGNAN | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| NO20065079L (no) | Materialer og metoder for behandling av koaguleringssykdommer | |
| RU2009126741A (ru) | Ингибиторы ренина, предназначенные для профилактики и лечения гипертензии у пациентов, страдающих от ожирения | |
| MX2007004020A (es) | Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20120614 |